Obstructive Cardiomyopathy, Hypertrophic research hub
3 indexed studies · 2 currently recruiting
- recruitingPHASE3
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
This study is looking at a new medication, sotagliflozin, to see if it can help people with a heart condition called hypertrophic cardiomyopathy (HCM). It aims to find out if the drug improves symptoms and daily activities compared to a dummy pill.
United States · Argentina · Belgium - recruitingPHASE2
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
This study is looking into a new medication called ninerafaxstat for people with a heart condition called non-obstructive hypertrophic cardiomyopathy (nHCM). It aims to see if the drug is safe and helps improve symptoms like breathlessness and tiredness.
United States · Austria · Belgium - ongoing, recruitingTherapeutic confirmatory (Phase III)
BMS CV027-031, A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
This study is looking at a new medicine called Mavacamten for adults with a heart condition called non-obstructive hypertrophic cardiomyopathy. It aims to see if the medicine can make people feel better and improve their exercise ability over 48 weeks.
Czechia · Belgium · Norway